Thank you, Mr. Speaker. Mr. Speaker, it is standard practice for utilities everywhere in the country that there's not any provisions whereby they would compensate customers who might find themselves in circumstances if they have some damages so there's no difference here with NTPC. Thank you.

Thank you, Mr. Chair. Mr. Chair, there's a couple of factors that can be -- that can result in the increase. First is there is -- well, primarily is that there was -- there was and continues to be a plan to reduce the overall lease footprint and to get to a place where we have less footprint and therefore less costs, and that was being built in. Unfortunately, some of that work is taking a little longer to get to, and as a result so while they have reduced the budget for leases, they ultimately found that there was base rent, then base rent escalations by landlords and also operations and...

Thank you, Mr. Chair. I can tell you that with respect to the public health nurses, there were seven nurses involved. Community health had two staff involved. Public health practitioners had two folks involved. There was a physician -- one physician involved, lab technologists involved, two laboratory clerks involved, one medical radiation technologist involved. Obviously, some of those individuals, this is not necessarily full-time work and wouldn't -- would likely have required some additional efforts and additional time and staffing in order to manage the expanding workload. Thank you.

That is accurate, Mr. Chair. Thank you.

Thank you, Mr. Chair. Mr. Chair, it -- yes, so it should be from 2024-2025 there is the slight surplus of $257,000 and that's being, again, put there, so, yes, it should reflect the total impacts from anything that happened over the course of the year. Thank you.

Thank you, Mr. Chair. Mr. Chair, I don't have that level of detail here. I'm not sure if -- no, I don't have that level of detail, Mr. Chair.

That would be the then total, Mr. Chair.

Thank you, Mr. Chair. $257,000.

Thank you, Mr. Chair. So two issues there. One is the chemotherapy drugs specifically which is what this particular item is in relation to. The services here, obviously costs are going up, drug costs are going up. There are some recoveries and some rebates as a result of agreements that are being signed in terms of providing the ability to seek some lower cost drugs, but we do have a shortage at $484,000. There's more clients requiring the drugs and then also the fact that the drugs are more costly.

Mr. Chair, more broadly, with drug-related costs and expenditures, certainly, again, I would...

Thank you, Mr. Chair. Yes, Mr. Chair, so earlier in the fall, or I guess now in the fall, I had written to make that request. I have recently had an opportunity to be in contact with the Minister of Finance for the federal government who has confirmed that the matter is moving forward. We don't have a final confirmation. There is an internal process within the federal government that they go through, but I understand that that is underway. So I had hoped to have a final confirmation of that obviously before we are now in our own budget session but we are confident, given the information that I...